Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies | Zendy

Jonathan Z. Li | Zendy; Evgenia Aga | Zendy; Ronald J. Bosch | Zendy; Mark A. Pilkinton | Zendy; Eugène Kroon | Zendy; Lynsay MacLaren | Zendy; Michael C. Keefer | Zendy; Lawrence Fox | Zendy; Elizabeth Barr | Zendy; Edward P. Acosta | Zendy; Jintanat Ananworanich | Zendy; Robert W. Coombs | Zendy; John W. Mellors | Zendy; Alan Landay | Zendy; Bernard Macatangay | Zendy; Steven G. Deeks | Zendy; Rajesh T. Gandhi | Zendy; Davey M. Smith | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies

Author(s) -

Jonathan Z. Li,

Evgenia Aga,

Ronald J. Bosch,

Mark A. Pilkinton,

Eugène Kroon,

Lynsay MacLaren,

Michael C. Keefer,

Lawrence Fox,

Elizabeth Barr,

Edward P. Acosta,

Jintanat Ananworanich,

Robert W. Coombs,

John W. Mellors,

Alan Landay,

Bernard Macatangay,

Steven G. Deeks,

Rajesh T. Gandhi,

Davey M. Smith

Publication year - 2021

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciab541

Subject(s) - medicine , antiretroviral therapy , virology , viral load , human immunodeficiency virus (hiv) , intensive care medicine , covid-19 , drug holiday , infectious disease (medical specialty) , disease , outbreak

Development of human immunodeficiency virus (HIV) remission strategies requires precise information on time to HIV rebound after treatment interruption, but there is uncertainty regarding whether modern antiretroviral therapy (ART) regimens and timing of ART initiation may affect this outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research